Tenax Therapeutics, Inc. (TENX)

NASDAQ: TENX · Real-Time Price · USD

14.60

-0.51 (-3.38%)

At close: Apr 28, 2026, 4:00 PM EDT

14.88

+0.28 (1.92%)

After-hours: Apr 28, 2026, 4:56 PM EDT

Tenax Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2020 - 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	2020 - 2016
Selling, General & Admin	23.71	6.79	5.01	5.68	6.38	Upgrade
Research & Development	32.67	12.71	3.23	5.38	25.15	Upgrade
Operating Expenses	56.39	19.49	8.23	11.05	31.53	Upgrade
Operating Income	-56.39	-19.49	-8.23	-11.05	-31.53	Upgrade
Interest Expense	-	-0.02	-0.02	-0	-0	Upgrade
Interest & Investment Income	3.82	1.91	0.48	-	-	Upgrade
Other Non Operating Income (Expenses)	-0.03	0	0.06	0.01	0.02	Upgrade
EBT Excluding Unusual Items	-52.6	-17.6	-7.71	-11.05	-31.51	Upgrade
Gain (Loss) on Sale of Investments	-	-	-	-	-0.01	Upgrade
Gain (Loss) on Sale of Assets	-	-	-	0	-	Upgrade
Other Unusual Items	-	-	-	-	-0.95	Upgrade
Pretax Income	-52.6	-17.6	-7.71	-11.05	-32.47	Upgrade
Net Income	-52.6	-17.6	-7.71	-11.05	-32.47	Upgrade
Net Income to Common	-52.6	-17.6	-7.71	-11.05	-32.47	Upgrade
Shares Outstanding (Basic)	39	15	0	0	0	Upgrade
Shares Outstanding (Diluted)	39	15	0	0	0	Upgrade
Shares Change (YoY)	156.80%	6046.87%	1250.92%	43.00%	-	Upgrade
EPS (Basic)	-1.34	-1.15	-31.04	-600.72	-2525.03	Upgrade
EPS (Diluted)	-1.34	-1.15	-31.04	-600.72	-2525.03	Upgrade
Free Cash Flow	-35.8	-14.81	-5.9	-11.39	-10.86	Upgrade
Free Cash Flow Per Share	-0.91	-0.97	-23.76	-619.37	-844.53	Upgrade
EBITDA	-	-19.49	-8.23	-11.05	-31.52	Upgrade
D&A For EBITDA	-	0.01	0.01	0.01	0	Upgrade
EBIT	-56.39	-19.49	-8.23	-11.05	-31.53	Upgrade

Source: S&P Capital IQ. Standard template. Financial Sources.